By LifETIME CDT Student: Lauren Hope (University of Glasgow) Acute myeloid leukaemia (AML) is a malignancy of the blood, caused by a build-up of genetic mutations, which can lead to a lack of mature blood cells in the bloodstream. Current AML research includes the use of small animal models and 2D cell culture systems. Whilst …
By lifETIME CDT Administrator: Emma Lardner (University of Birmingham) Since the COVID-19 pandemic hit the UK earlier this year, we have worked hard to adapt the lifETIME programme to be delivered online. Our 2019 cohort were fortunate enough to be able to have in-person rotational training which created an environment to network with other cohort members, …
By LifETIME CDT Student: Hannah Lamont (University of Birmingham) Going into my PhD project, I knew little about glaucoma and how exactly it’s become the leading cause of irreversible blindness worldwide. Now, a year into my project and I’m completely fascinated by this disease and where exactly the crux of the problem lies; in two …
By LifETIME CDT Administrator: Emma Lardner (University of Birmingham) Delegates have attended the first virtual LifETIME CDT Student Day event bringing together academics, industry partners and LifETIME students. The event began with a welcome from Ivan Wall, Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing at Aston University who gave an informative overview of the …
By LifETIME CDT Student: Elena Mandrou (University of Glasgow) My project revolves around studying a signalling pathway that previous research showed it is important for the directional metastasis (or spread) of aggressive cancers. The signal in question is a lipid called lysophosphatidic acid (or LPA) that exists in the cells’ surroundings. The cells’ have a …
By LifETIME CDT Student: Lydia-Styliani Marinou (University of Glasgow) Once upon a time, the Lifetime CDT collaborated with the following CDTs and the UK Society of Biomaterials to organise a joint event this summer: EPSRC-SFI Joint CDT in Engineered Tissues for Discovery, Industry and Medicine (LifETIME) EPSRC/MRC CDT in Regenerative Medicine EPSRC/MRC CDT in Regenerative …